Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

SPROSPRO
6 quarters

Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in SPERO THERAPEUTICS INC

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds 332,970 shares of SPRO (SPERO THERAPEUTICS INC), worth $735,864 as of 2026-Q2. This is a new position. SPRO represents 0.0% of ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's portfolio.

Current Value

$735,864

Current Shares

332,970

Total Value Change

+$360,864

Total Shares Change

+305,228

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
332,970
-
$735,8640.0%$2.21
34
2025-Q4
Exited
0
-100.0%
$00.0%$2.27
0
2025-Q3
New
150,516
-
$282,9700.0%$1.90
32
2020-Q4
Exited
0
-100.0%
$00.0%$20.23
0
2020-Q3
Increased
34,225
+23.4%
$382,0000.0%$9.95
29
2020-Q2
New
27,742
-
$375,0000.0%$13.25
33

Other major holders of SPRO: BNP PARIBAS FINANCIAL MARKETS, Steward Partners Investment Advisory, LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used